Introducing Onsior – Effective Pain Relief For Cats And Dogs
16 years ago
13903 views
Posted
16th September, 2009 00h00
Onsior®, the first and only coxib NSAID (non-steroidal anti-inflammatory drug) for the relief of pain and inflammation in both cats and dogs, will be launched by Novartis Animal Health on September 15th 2009.
Traditionally, NSAIDs inhibit both COX-2 and COX-1 enzymes which can result in common side effects involving the gastrointestinal tract and the kidneys. Onsior, however, targets the pain-causing COX-2 enzymes while sparing the protective actions of COX-1 and is the only coxib licensed for cats as well as dogs.
Tissue selectivity is a further benefit of Onsior. The drug travels rapidly through the bloodstream to the site of injury or irritation. It then concentrates at the point of inflammation, while exiting the bloodstream very quickly.
Dosed once daily, Onsior has an excellent safety profile and fits different administration routes with pain and inflammatory indications, which are:- An injectable solution for surgery (soft tissue in cats and soft tissue or orthopaedic surgery in dogs)
- Flavoured tablets, for pain and inflammation related to chronic osteoarthritis in dogs or acute pain and inflammation associated with musculoskeletal disorders in cats
More from
- Vetsure Named Business of the Year at 2025 SME National Business Awards
- Home of hope for Romania's dogs: The pioneering shelter doing things differently
- Pioneering new locum platform transforming veterinary landscape
- Key Stakeholders unite to advance helmet design for equine veterinary professionals
- Hallmarq hails transformational equine imaging technology

1 hour ago